(Allergan plc)

	AGN latest price $137.5100 (-1.89%) ($137.2900 - $140.9800) on Wed. Mar. 6, 2019.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.19% (three month average)
RSI	45
Latest Price	$137.5100(-1.89%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.2% a day on average for past five trading days.
Weekly Trend	AGN advances 0.1% a week on average for past two weeks.
Market Behavior	Broad based sell-off for large cap. Broad based sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(49%)    ARKG(47%)    XLV(47%)    XBI(46%)    IVE(45%)
Factors Impacting AGN price	AGN will decline at least -1.095% in a week (0% probabilities).   VIXM(-25%)    UUP(-23%)    TLT(-23%)    IFRA(-16%)    XHB(-15%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.095% (StdDev 2.19%)
Hourly BBV	0 ()
Intraday Trend	-2.1%

5 Day Moving Average	$139.04(-1.1%)
10 Day Moving Average	$137.79(-0.2%)
20 Day Moving Average	$137.3(0.15%)
To recent high	-14%
To recent low	6.5%
Market Cap	$45.337b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed